8.72
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NEO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.42
Aprire:
$9
Volume 24 ore:
1.90M
Relative Volume:
1.57
Capitalizzazione di mercato:
$1.12B
Reddito:
$628.25M
Utile/perdita netta:
$-78.55M
Rapporto P/E:
-14.06
EPS:
-0.62
Flusso di cassa netto:
$-29.73M
1 W Prestazione:
-8.02%
1M Prestazione:
-8.98%
6M Prestazione:
-38.24%
1 anno Prestazione:
-41.36%
Neogenomics Inc Stock (NEO) Company Profile
Nome
Neogenomics Inc
Settore
Industria
Telefono
(239) 768-0600
Indirizzo
9490 NEOGENOMICS WAY, FORT MYERS, FL
Confronta NEO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NEO
Neogenomics Inc
|
8.72 | 1.12B | 628.25M | -78.55M | -29.73M | -0.62 |
![]()
TMO
Thermo Fisher Scientific Inc
|
470.03 | 177.32B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
197.90 | 141.59B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
IDXX
Idexx Laboratories Inc
|
410.76 | 33.29B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
109.67 | 31.28B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
167.69 | 29.57B | 15.41B | 1.37B | 2.11B | 7.50 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-13 | Downgrade | The Benchmark Company | Buy → Hold |
2024-12-10 | Iniziato | Jefferies | Buy |
2024-05-01 | Ripresa | Craig Hallum | Buy |
2023-12-29 | Reiterato | BTIG Research | Buy |
2023-08-21 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2023-05-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
2023-05-09 | Aggiornamento | BTIG Research | Neutral → Buy |
2023-02-24 | Aggiornamento | The Benchmark Company | Hold → Buy |
2023-02-01 | Aggiornamento | Needham | Hold → Buy |
2022-08-26 | Downgrade | The Benchmark Company | Buy → Hold |
2022-08-22 | Downgrade | Needham | Buy → Hold |
2022-06-03 | Iniziato | Piper Sandler | Overweight |
2022-03-29 | Downgrade | BofA Securities | Buy → Neutral |
2022-03-29 | Downgrade | Stephens | Overweight → Equal-Weight |
2022-01-18 | Ripresa | Stephens | Overweight |
2021-12-16 | Iniziato | Cowen | Outperform |
2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-10-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2021-06-03 | Iniziato | Goldman | Buy |
2021-02-25 | Ripresa | Needham | Buy |
2021-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
2021-01-28 | Iniziato | Truist | Buy |
2020-12-11 | Ripresa | BTIG Research | Buy |
2020-10-28 | Reiterato | Needham | Buy |
2020-09-09 | Iniziato | Morgan Stanley | Overweight |
2020-08-28 | Iniziato | Guggenheim | Buy |
2020-07-29 | Reiterato | Needham | Buy |
2020-06-25 | Iniziato | BofA/Merrill | Buy |
2020-04-21 | Ripresa | Stephens | Overweight |
2020-03-02 | Ripresa | Craig Hallum | Buy |
2020-02-28 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
2020-01-23 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
2019-10-30 | Reiterato | Needham | Buy |
2019-05-01 | Reiterato | Needham | Buy |
2019-03-29 | Reiterato | Needham | Buy |
2019-01-03 | Iniziato | Needham | Buy |
2018-10-24 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
2018-08-21 | Iniziato | Leerink Partners | Outperform |
2018-05-02 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
2017-09-11 | Downgrade | BTIG Research | Buy → Neutral |
2017-08-24 | Iniziato | Gabelli & Co | Buy |
2016-12-15 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Neogenomics Inc Borsa (NEO) Ultime notizie
NeoGenomics stock hits 52-week low at $8.9 amid challenges - Investing.com Australia
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) - The Globe and Mail
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes - ACCESS Newswire
NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019 - ACCESS Newswire
NeoGenomics announces CEO transition - MSN
New CEO assumes role at NeoGenomics - Gulfshore Business
NeoGenomics appoints Tony Zook as CEO - Investing.com
NeoGenomics, Inc. Announces CEO Changes - MarketScreener
Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics - BioSpace
NeoGenomics appoints Tony Zook as CEO By Investing.com - Investing.com Australia
NeoGenomics Appoints Tony Zook Chief Executive - MarketScreener
NeoGenomics' New CEO Zook Takes Over as Smith Retires - MarketWatch
Tony Zook Assumes Role As Chief Executive Officer Of Neogenomics - MarketScreener
Diagnostic Leader NeoGenomics Taps 30-Year Veteran to Drive Oncology Testing Growth - Stock Titan
Benchmark maintains Hold on Neogenomics stock, reiterates price target By Investing.com - Investing.com Canada
Where are the Opportunities in (NEO) - news.stocktradersdaily.com
3 Reasons to Sell NEO and 1 Stock to Buy Instead - Yahoo Finance
Piper Sandler maintains Neogenomics stock with $18 target - Investing.com
Piper Sandler maintains Neogenomics stock with $18 target By Investing.com - Investing.com UK
NeoGenomics elevates Warren Stone to President and COO By Investing.com - Investing.com Australia
NeoGenomics Promotes Warren Stone to President & COO - TipRanks
Fort Myers-based NeoGenomics names new COO - Gulfshore Business
Earnings call transcript: NeoGenomics Q4 2024 results disappoint despite EPS beat - Investing.com
NeoGenomics elevates Warren Stone to President and COO - Investing.com
NeoGenomics Names Warren Stone President, COO -March 18, 2025 at 08:09 am EDT - Marketscreener.com
NeoGenomics Appoints Warren Stone as President & Chief Operating Officer - Lelezard
NeoGenomics Appoints Warren Stone As President & Chief Operating Officer -March 18, 2025 at 07:10 am EDT - Marketscreener.com
Commit To Buy NeoGenomics At $8, Earn 19.6% Annualized Using Options - Nasdaq
NeoGenomics (NASDAQ:NEO) Stock Price Up 7.2%Here's What Happened - MarketBeat
SBI Securities Co. Ltd. Invests $26,000 in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics at Barclays Healthcare: Strategic Focus on Innovation - Investing.com India
Bank of New York Mellon Corp Purchases 15,269 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics, Inc. (NASDAQ:NEO) Receives $19.60 Average Target Price from Analysts - Defense World
NeoGenomics at Leerink Global Healthcare: Strategic Transition and Growth By Investing.com - Investing.com South Africa
(NEO) Technical Pivots with Risk Controls - news.stocktradersdaily.com
NeoGenomics at Leerink Global Healthcare: Strategic Transition and Growth - Investing.com
Fort Myers-based NeoGenomics expands cancer testing reach with acquisition - News-Press
Proficio Capital Partners LLC Invests $372,000 in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
BTIG maintains $17 target on Neogenomics stock post-acquisition By Investing.com - Investing.com UK
NeoGenomics Acquires Pathline -March 10, 2025 at 08:13 am EDT - Marketscreener.com
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline - BioSpace
NeoGenomics expands with Pathline acquisition - Investing.com India
NeoGenomics expands with Pathline acquisition By Investing.com - Investing.com South Africa
NeoGenomics Expands Oncology Testing Reach In The Northeast With Acquisition Of Pathline - Marketscreener.com
Smartleaf Asset Management LLC Has $70,000 Position in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R) - ACCESS Newswire
NeoGenomics, Inc.'s (NASDAQ:NEO) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors - Simply Wall St
NeoGenomics, Inc. to Host Earnings Call - ACCESS Newswire
NeoGenomics price target lowered to $17 from $18 at BTIG - MSN
NeoGenomics at TD Cowen Conference: CEO Transition and Growth Plans By Investing.com - Investing.com UK
NeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Truist Financial Corp - Defense World
Neogenomics Inc Azioni (NEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):